FDA Johnson & Johnson

News

FDA, Ozempic

Johnson & Johnson CEO warns US tariffs may disrupt drug supply

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain disruptions and that favorable tax policies would be a more effective tool to boost U.

FOX News on MSN · 2h

Fake Ozempic drugs found in US drug supply, FDA warns

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products that should not be used, sold or distributed.

Yahoo · 1d

FDA offers new warning over fake versions of Ozempic

The FDA says fake versions of Ozempic are being sold outside of the authorized supply chain. The agency reminds consumers to only get the medication with a valid prescription through state-licensed pharmacies.

1don MSN

Tariffs won’t boost U.S. manufacturing — tax cuts will, Johnson & Johnson CEO says

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

Fierce Biotech8d

J&J links FcRn blocker to sustained benefits as FDA ruling on potential blockbuster nears

If the FDA approves nipocalimab, the long-term data could form part of J&J’s pitch for the gMG market. The labels for ...

STAT13d

Pharmalittle: We’re reading about a pharma tariff exception, FDA inspection cutbacks, and more

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...

Fierce Pharma1d

As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

The Human Side of Tech-Enabled Healthcare

Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists.

JNJ Earnings: Johnson & Johnson Posts Quarterly Beat and Raises Full-Year Sales Guidance

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Fierce Pharma5d

After Hetlioz's rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use

After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda ...

CDC doctor monitoring bad COVID vaccine reactions may have deleted files, alleges Sen. Ron Johnson

Officials at the Department of Health and Human Services have struggled to find records belonging to Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results